Banner MD Anderson names new director
Rogerio Lilenbaum, MD, begins new role on Feb. 3,
He’s an experienced, forward-thinking health care leader, and the team in Houston looks forward to working with him


GILBERT, Ariz. (Dec. 23, 2019) -- Banner MD Anderson Cancer Center recently named Rogerio Lilenbaum, MD, as its new director. He’ll begin the new role on Feb. 3, providing leadership, vision, direction and development of all Banner MD Anderson clinical programs and its enterprise-wide efforts.

He joins Banner from Yale New Haven Health and Yale School of Medicine, where he most recently served as chief medical integration officer for ambulatory services. Between 2013 and 2018, Lilenbaum served as the first chief medical officer for the Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven. There he oversaw clinical programs, clinical operations, as well as quality, safety and network development for the cancer program.

“Our relationship with Banner MD Anderson is strengthened with Dr. Lilenbaum joining the team,” said Michael Kupferman, MD, senior vice president, Clinical and Academic Network Development for MD Anderson Cancer Network. “He’s an experienced, forward-thinking health care leader, and the team in Houston looks forward to working with him.”

Prior to 2013, Lilenbaum was chairman of the Cancer Institute at the Cleveland Clinic in Florida.

Lilenbaum received his medical degree from the Federal University of Rio de Janeiro School of Medicine in Brazil, and earned a Master of Science in clinical epidemiology and clinical investigation from the Harvard School of Public Health. He completed his hematology/oncology fellowship at Washington University School of Medicine and a clinical and research fellowship at the University of California San Diego. Lilenbaum is a board-certified medical oncologist with expertise in thoracic malignancies. He has authored more than 100 peer-reviewed papers and book chapters.

“His experience in leading oncology care and stellar reputation within oncology circles will enable
Banner MD Anderson to continue elevating our research-driven, multidisciplinary, customer-centered clinical mission,” said Becky Kuhn, Banner Health’s chief operating officer.

Banner MD Anderson, located on the Banner Gateway campus, delivers cancer care to patients in Arizona through the partnership of Banner Health and MD Anderson Cancer Center. Banner MD Anderson offers focused disease-specific expertise in the medical, radiation and surgical management of the cancer patient; an evidence-based, multidisciplinary approach to patient care; access to clinical trials and new investigative therapies; state-of-the-art technology for the diagnosis, staging and treatment of all types of cancer; oncology expertise in supportive care services. For more information, visit